Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive role of polymorphic variants of phase II drug metabolising enzyme in modulating toxicity in North Indian lung cancer patients undergoing chemotherapy. | Xenobiotica | 2022 | 35445643 | PubTator, text mining | PubMed |
| Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis. | Int J Gen Med | 2022 | 35431572 | PubTator, text mining | PubMed |
| Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. | Cancers (Basel) | 2022 | 35406495 | PubTator, text mining | PubMed |
| Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. | Nutrients | 2022 | 35406059 | PubTator, text mining | PubMed |
| Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. | Int J Cancer | 2022 | 35404482 | PubTator, text mining | PubMed |
| [Association of SCN2A, ABCB1 and CYP2C19*3 with genetic susceptibility to major depressive disorder]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2022 | 35381649 | PubTator, text mining | PubMed |
| Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma. | J Cancer | 2022 | 35371307 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine. | Front Pharmacol | 2022 | 35370680 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population. | Hum Genomics | 2022 | 35366956 | PubTator, text mining | PubMed |
| Investigation of hub genes involved in Turner syndrome using biological informatics methods. | Medicine (Baltimore) | 2022 | 35356930 | PubTator, text mining | PubMed |
| Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells. | Toxicol Appl Pharmacol | 2022 | 35353990 | PubTator, text mining | PubMed |
| Time for Isoniazid Pharmacogenomic-Guided Therapy of Tuberculosis Based on NAT2 Acetylation Profiles in India. | Eur J Drug Metab Pharmacokinet | 2022 | 35349098 | PubTator, text mining | PubMed |
| Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study. | Kidney360 | 2022 | 35342886 | PubTator, text mining | PubMed |
| Identification of critical residues of O-antigen-modifying O-acetyltransferase B (OacB) of Shigella flexneri. | BMC Mol Cell Biol | 2022 | 35331134 | PubTator, text mining | PubMed |
| Untangling SNP Variations within CYP2D6 Gene in Croatian Roma. | J Pers Med | 2022 | 35330374 | PubTator, text mining | PubMed |
| Personalized Management and Treatment of Alzheimer's Disease. | Life (Basel) | 2022 | 35330211 | PubTator, text mining | PubMed |
| Genome-Wide Association Study Adjusted for Occupational and Environmental Factors for Bladder Cancer Susceptibility. | Genes (Basel) | 2022 | 35328002 | PubTator, text mining | PubMed |
| Mercury and Mercury-Containing Preparations: History of Use, Clinical Applications, Pharmacology, Toxicology, and Pharmacokinetics in Traditional Chinese Medicine. | Front Pharmacol | 2022 | 35308204 | PubTator, text mining | PubMed |
| Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus. | Ther Clin Risk Manag | 2022 | 35308097 | PubTator, text mining | PubMed |
| The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness. | Cancer Med | 2022 | 35285182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=25